210 related articles for article (PubMed ID: 15512883)
1. ALSFRS-R.
Gordon PH; Miller RG; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():90-3. PubMed ID: 15512883
[TBL] [Abstract][Full Text] [Related]
2. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
[TBL] [Abstract][Full Text] [Related]
3. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
4. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
5. Outcome measures for early phase clinical trials.
Gordon PH; Cheng B; Montes J; Doorish C; Albert SM; Mitsumoto H
Amyotroph Lateral Scler; 2007 Oct; 8(5):270-3. PubMed ID: 17852017
[TBL] [Abstract][Full Text] [Related]
6. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
[TBL] [Abstract][Full Text] [Related]
7. Non-self-sufficiency as a primary outcome measure in ALS trials.
Marin B; Bianchi E; Pupillo E; Lunetta C; Tremolizzo L; Logroscino G; Chiò A; Preux PM; Beghi E
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):77-84. PubMed ID: 26470831
[TBL] [Abstract][Full Text] [Related]
8. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R.
Kasarskis EJ; Dempsey-Hall L; Thompson MM; Luu LC; Mendiondo M; Kryscio R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):50-4. PubMed ID: 16036426
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance in the change of decline in ALSFRS-R.
Castrillo-Viguera C; Grasso DL; Simpson E; Shefner J; Cudkowicz ME
Amyotroph Lateral Scler; 2010; 11(1-2):178-80. PubMed ID: 19634063
[TBL] [Abstract][Full Text] [Related]
10. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a self-administered version of the ALSFRS-R.
Montes J; Levy G; Albert S; Kaufmann P; Buchsbaum R; Gordon PH; Mitsumoto H
Neurology; 2006 Oct; 67(7):1294-6. PubMed ID: 17030772
[TBL] [Abstract][Full Text] [Related]
12. [Disease activity measures for rheumatoid arthritis clinical trials].
Kondo H
Ryumachi; 1997 Dec; 37(6):825-31. PubMed ID: 9492571
[No Abstract] [Full Text] [Related]
13. Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index.
De Groot IJ; Post MW; Van Heuveln T; Van Den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2006 Sep; 7(3):167-72. PubMed ID: 16963406
[TBL] [Abstract][Full Text] [Related]
14. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
15. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference.
Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A
Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436
[TBL] [Abstract][Full Text] [Related]
17. [Functional scales and motor assessment in amyotrophic lateral sclerosis].
Benaïm C; Desnuelle C; Fournier-Méhouas M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S131-4S137. PubMed ID: 17128101
[TBL] [Abstract][Full Text] [Related]
18. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
[TBL] [Abstract][Full Text] [Related]
19. The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
Berry JD; Miller R; Moore DH; Cudkowicz ME; van den Berg LH; Kerr DA; Dong Y; Ingersoll EW; Archibald D
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):162-8. PubMed ID: 23323713
[TBL] [Abstract][Full Text] [Related]
20. Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes.
Lechtzin N; Maragakis NJ; Kimball R; Busse A; Hoffman V; Clawson L
Amyotroph Lateral Scler; 2009 Aug; 10(4):244-7. PubMed ID: 18985465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
